MINI REVIEW
Published on 07 Jul 2022
Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance
doi 10.3389/fonc.2022.934240
- 5,302 views
- 12 citations
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Treatment Strategies for Patients with Multiple Myeloma: from Clinical Trials to Real Life
Treatment Strategies for Patients with Multiple Myeloma: from Clinical Trials to Real Life
8,663
Total downloads
36k
Total views and downloads
Articles
REVIEW
Published on 11 May 2022
Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World Results
doi 10.3389/fonc.2022.844779
- 6,435 views
- 17 citations
BRIEF RESEARCH REPORT
Published on 14 Mar 2022
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
doi 10.3389/fonc.2022.851864
- 3,114 views
- 14 citations
MINI REVIEW
Published on 09 Mar 2022
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
doi 10.3389/fonc.2022.830922
- 4,072 views
- 14 citations
REVIEW
Published on 20 Jan 2022
Where We Stand With Precision Therapeutics in Myeloma: Prosperity, Promises, and Pipedreams
doi 10.3389/fonc.2021.819127
- 3,964 views
- 15 citations
ORIGINAL RESEARCH
Published on 17 Nov 2021
Ultra-Low-Dose Whole-Body Computed Tomography Protocol Optimization for Patients With Plasma Cell Disorders: Diagnostic Accuracy and Effective Dose Analysis From a Reference Center
doi 10.3389/fonc.2021.769295
- 8,626 views
- 1 citation
ORIGINAL RESEARCH
Published on 15 Jun 2021
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients
doi 10.3389/fonc.2021.682658
- 1,844 views
- 3 citations
ORIGINAL RESEARCH
Published on 28 May 2021
Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan
doi 10.3389/fonc.2021.695410
- 4,189 views
- 3 citations
